Cases 1 - 7 of 7
UCB, Inc. et al v. Mylan Technologies Inc.
as 2:2022cv00216
Plaintiff:
UCB, Inc., UCB Pharma GmbH and LTS Lohmann Therapie-Systeme AG
Defendant:
Mylan Technologies Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
UCB, Inc. et al v. Mylan Technologies, Inc.
as 2:2019cv00128
Plaintiff:
UCB Pharma GmbH, UCB, Inc. and LTS Lohmann Therapie-Systeme AG
Defendant:
Mylan Technologies, Inc.
Cause Of Action: 35 U.S.C. § 271
UCB, Inc. et al v. Mylan Technologies, Inc. et al
as 2:2019cv00148
Plaintiff:
UCB, Inc., LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH and others
Defendant:
Mylan Pharmaceuticals, Inc., Mylan Technologies, Inc. and Mylan, Inc.
Counter Claimant:
Mylan Technologies Inc.
Cause Of Action: 35 U.S.C. § 271
UCB, Inc. et al v. Apotex Inc.
as 1:2018cv03404
Plaintiff:
UCB, Inc. and UCB Biopharma SPRL
Defendant:
Apotex Inc.
Cause Of Action: 35 U.S.C. § 271
UCB, Inc. et al v. InvaGen Pharmaceuticals, Inc.
as 2:2015cv06919
Counter Claimant:
InvaGen Pharmaceuticals, Inc.
Counter Defendant:
InvaGen Pharmaceuticals, Inc.
Defendant:
InvaGen Pharmaceuticals, Inc.
Plaintiff:
UCB Pharma S.A. and UCB, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Breckenridge Pharmaceutical, Inc. v. UCB, Inc. et al
as 1:2011cv07785
Plaintiff:
Breckenridge Pharmaceutical, Inc.
Defendant:
UCB, Inc. and Kremers Urban Pharmaceuticals, Inc.
Cause Of Action: 28 U.S.C. § 1331
Rotondi et al v. Schwarz Pharma AG et al
as 3:2008cv00804
Plaintiff:
Anthony Rotondi, Anthony Rotondi, Anthony Rotondi and others
Defendant:
Schwarz Pharma AG, Schwarz Pharma AG, Schwarz Pharma Inc and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Personal Injury
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
